news
Organoid drug testing predicts bowel cancer treatment response
A new study proves that organoid drug testing is highly accurate at predicting effective treatments and finds a novel therapeutic option.
List view / Grid view
Bowel cancer
news
Targeting Ku70 could improve bowel cancer treatment
The Ku70 protein prevents cancer cells from becoming more aggressive and metastasising. It could also be used as an immune biomarker.
news
Novel vaccine protects mice from lung, bowel and pancreatic cancer
By targeting the mutated KRAS gene, researchers have developed an experimental vaccine that protected mice against a range of cancers.
news
Scientists can now ‘listen in’ on cancer cells with new technique
More effective drugs could be developed due to a new technique that has allowed scientists to decipher how millions of individual cells are communicating with each other on miniature tumours grown in a lab.
news
Study reveals every bowel tumour and bowel cancer cell have unique genetic fingerprints
Single-cell technology and organoids enable researchers to study cancer-specific processes...
news
Researchers produce the first draft cell atlas of the small intestine
By surveying gene expression, researchers have created a reference atlas for understanding the biology of inflammatory bowel disease and food allergies, among other conditions...
news
CRISPR used to identify drug target for bowel cancer
CRISPR used to identify a new drug target for bowel cancer that is specific to tumour cells and therefore less toxic than conventional therapies...
news
New web calculator to more accurately predict bowel cancer survival
For many bowel cancer patients, following the initial shock of their diagnosis, thoughts quickly turn to estimating how much time they have to live...
article
Creating the ‘google earth’ of tumours
We caught up with Dr Josephine Bunch to find out how NPL are using the Cancer Research Grand Challenge funding & novel imaging techniques to map cancer tumours...
news
Bowel cancer medication could help combat early-onset Parkinson’s disease
People with certain forms of early-onset Parkinson’s disease could potentially benefit from taking a medication used to treat certain forms of cancer.
news
Glutamine-depriving drugs block bowel cancer tumour
21 July 2016 | By Niamh Louise Marriott, Digital Content Producer
A new scientific study using mice has identified why cancer cells depend on glutamine to reprogram their metabolism - and a way to starve them of it...